Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Scheid

Showing results (41-50 of 199) with videos related to

Pageof 20
Sort By:
Cancers|December 23, 2023
Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical TrialsEdward Laane, Sam Salek, Esther Natalie Oliva, et al.
European Journal of Haematology|October 23, 2015
Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibodyGeothy Chakupurakal, María Alejandra García-Márquez, Alexander Shimabukuro-Vornhagen, et al.
European Journal of Haematology|April 15, 2024
Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma-Final results of the phase II OCTET-EVER trialTim Richardson, Christof Scheid, Marco Herling, et al.
European Journal of Haematology|April 13, 2017
Dynamics of BKPyV reactivation and risk of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantationKonstantin Höller, Lavinia Fabeni, Marco Herling, et al.
Annals of Hematology|May 18, 2011
Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemiaJens Marcus Chemnitz, Marie von Lilienfeld-Toal, Udo Holtick, et al.
Leukemia Research|April 12, 2026
Retrospective, single-center analysis of second allogeneic stem cell transplantation versus non-transplant regimens for acute myeloid leukemia patients with relapse after first transplantationDaniel Schütte, Eva-Maria Call, Moritz Fürstenau, et al.
Bone Marrow Transplantation|November 15, 2024
Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphomaTim Richardson, Hishan Tharmaseelan, Lukas Frenzel, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 20, 2020
Detection of systemic immunosuppressants in autologous serum eye drops (ASED) in patients with severe chronic ocular graft versus host diseaseVolkan Tahmaz, Martin H J Wiesen, Uta Gehlsen, et al.
International Journal of Antimicrobial Agents|January 11, 2012
Intracellular concentrations of micafungin in different cellular compartments of the peripheral bloodFedja Farowski, Oliver A Cornely, Jörg J Vehreschild, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 3, 2004
Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapyChristof Scheid, Karin Hermann, Gisela Kremer, et al.
Pageof 20

Showing results (41-50 of 199) with videos related to

Sort By:
Pageof 20
Cancers|December 23, 2023
Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical TrialsEdward Laane, Sam Salek, Esther Natalie Oliva, et al.
European Journal of Haematology|October 23, 2015
Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibodyGeothy Chakupurakal, María Alejandra García-Márquez, Alexander Shimabukuro-Vornhagen, et al.
European Journal of Haematology|April 15, 2024
Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma-Final results of the phase II OCTET-EVER trialTim Richardson, Christof Scheid, Marco Herling, et al.
European Journal of Haematology|April 13, 2017
Dynamics of BKPyV reactivation and risk of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantationKonstantin Höller, Lavinia Fabeni, Marco Herling, et al.
Annals of Hematology|May 18, 2011
Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemiaJens Marcus Chemnitz, Marie von Lilienfeld-Toal, Udo Holtick, et al.
Leukemia Research|April 12, 2026
Retrospective, single-center analysis of second allogeneic stem cell transplantation versus non-transplant regimens for acute myeloid leukemia patients with relapse after first transplantationDaniel Schütte, Eva-Maria Call, Moritz Fürstenau, et al.
Bone Marrow Transplantation|November 15, 2024
Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphomaTim Richardson, Hishan Tharmaseelan, Lukas Frenzel, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 20, 2020
Detection of systemic immunosuppressants in autologous serum eye drops (ASED) in patients with severe chronic ocular graft versus host diseaseVolkan Tahmaz, Martin H J Wiesen, Uta Gehlsen, et al.
International Journal of Antimicrobial Agents|January 11, 2012
Intracellular concentrations of micafungin in different cellular compartments of the peripheral bloodFedja Farowski, Oliver A Cornely, Jörg J Vehreschild, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 3, 2004
Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapyChristof Scheid, Karin Hermann, Gisela Kremer, et al.
Pageof 20